From: Serum GP73 predicts posthepatectomy outcomes in patients with hepatocellular carcinoma
Patient characteristics | n (%) |
---|---|
Age, mean ± SD (year) | 50.9 ± 11.5 |
Male, n (%) | 238 (85.0%) |
Diabetes, n (%) | 22 (7.9%) |
Hypertension, n (%) | 53 (18.9%) |
 Background liver disease | |
  HB | 176 |
  HC | 8 |
  HB and HC | 2 |
  Non-B non-C | 94 |
ASA grading, mean + SD | 2.3 ± 0.6 |
Hemoglobin, mean ± SD (g/dL) | 130.7 ± 19.7 |
White blood cell count, mean ± SD (109/L) | 5.5 ± 2.5 |
Platelet count, mean ± SD (109/L) | 135.8 ± 71.0 |
Total bilirubin, mean ± SD (μmol/L) | 24.4 ± 45.7 |
ALT, mean ± SD (U/L) | 54.2 ± 57.1 |
AST, mean ± SD (U/L) | 56.8 ± 63.2 |
INR, mean ± SD | 1.08 ± 0.1 |
Albumin, mean ± SD (g/L) | 39.1 ± 5.5 |
GP73, mean ± SD (ng/mL) | 111.8 ± 153.3 |
Child–Pugh score, mean ± SD | 5.6 ± 1.0 |
Child–Pugh grade (A/B/C) | 262/18/0 |
Size of largest tumor, mean ± SD (cm) | 6.2 ± 3.6 |
Solitary tumor, n (%) | 246 (87.9%) |
Blood loss, mean ± SD (min) | 805.8 ± 961.8 |
Intermittent hilar clamping, mean ± SD (min) | 14.3 ± 15.2 |
Operation time, mean ± SD (min) | 233.5 ± 200.2 |
Intraoperative procedures | |
 Minor hepatectomy | 199 |
 Major hepatectomy | 81 |
Clavien–Dindo classification | |
 Grade 1 | 35 |
 Grade 2 | 81 |
 Grade 3a/3b | 19/1 |
 Grade 4a/4b | 5/0 |
 Grade 5 | 4 |